embryonic stem cells human medium spiny projection neurons midkine signaling neuronal differentiation protocol retinoic acid single-cell RNA-seq striatal development

Journal

Cell reports methods
ISSN: 2667-2375
Titre abrégé: Cell Rep Methods
Pays: United States
ID NLM: 9918227360606676

Informations de publication

Date de publication:
19 12 2022
Historique:
received: 23 08 2022
revised: 06 10 2022
accepted: 16 11 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 3 1 2023
Statut: epublish

Résumé

Stem cell engineering of striatal medium spiny neurons (MSNs) is a promising strategy to understand diseases affecting the striatum and for cell-replacement therapies in different neurological diseases. Protocols to generate cells from human pluripotent stem cells (PSCs) are scarce and how well they recapitulate the endogenous fetal cells remains poorly understood. We have developed a protocol that modulates cell seeding density and exposure to specific morphogens that generates authentic and functional D1- and D2-MSNs with a high degree of reproducibility in 25 days of differentiation. Single-cell RNA sequencing (scRNA-seq) shows that our cells can mimic the cell-fate acquisition steps observed

Identifiants

pubmed: 36590694
doi: 10.1016/j.crmeth.2022.100367
pii: S2667-2375(22)00269-7
pmc: PMC9795363
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100367

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

All authors declare no competing interests.

Références

Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
PLoS One. 2013 Dec 04;8(12):e82076
pubmed: 24324748
Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Nat Biotechnol. 2020 Dec;38(12):1408-1414
pubmed: 32747759
Mech Dev. 1999 Feb;80(2):185-9
pubmed: 10072786
Neurobiol Dis. 2020 Dec;146:105140
pubmed: 33065279
Development. 2013 Jan 15;140(2):301-12
pubmed: 23250204
Nat Commun. 2021 Feb 17;12(1):1088
pubmed: 33597522
Nat Neurosci. 2014 Dec;17(12):1804-15
pubmed: 25383901
Science. 2021 May 7;372(6542):
pubmed: 33958447
Development. 2018 Jan 29;145(2):
pubmed: 29378824
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
J Huntingtons Dis. 2021;10(2):221-226
pubmed: 33814456
Nat Rev Neurosci. 2013 Apr;14(4):278-91
pubmed: 23511908
Neuron. 2015 Apr 8;86(1):187-206
pubmed: 25856494
Stem Cell Reports. 2018 May 8;10(5):1481-1491
pubmed: 29628395
Nat Commun. 2021 Apr 20;12(1):2340
pubmed: 33879786
Anat Res Int. 2012;2012:106529
pubmed: 22567304
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Nat Commun. 2016 Dec 09;7:13602
pubmed: 27934856
J Neurochem. 2008 Dec;107(6):1471-81
pubmed: 19094054
Stem Cells. 2013 Sep;31(9):1763-74
pubmed: 23818270
Stem Cell Reports. 2018 Sep 11;11(3):635-650
pubmed: 30174316
Nat Neurosci. 2021 Dec;24(12):1745-1756
pubmed: 34737447
Fluids Barriers CNS. 2015 May 21;12:13
pubmed: 25994964
Trends Neurosci. 1992 Apr;15(4):133-9
pubmed: 1374971
Development. 1999 Mar;126(6):1317-26
pubmed: 10021349
Science. 2021 Dec 10;374(6573):eabj6641
pubmed: 34882453
Stem Cell Reports. 2020 Mar 10;14(3):406-419
pubmed: 32109367
Bioinformatics. 2020 Feb 1;36(3):964-965
pubmed: 31400197
Cell Stem Cell. 2012 Apr 6;10(4):455-64
pubmed: 22424902
Development. 2015 Apr 1;142(7):1375-86
pubmed: 25804741

Auteurs

Paola Conforti (P)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Vittoria Dickinson Bocchi (VD)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Ilaria Campus (I)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Linda Scaramuzza (L)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Maura Galimberti (M)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Tiziana Lischetti (T)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Francesca Talpo (F)

Department of Biology and Biotechnologies, University of Pavia, Via Adolfo Ferrata, 9, 27100 Pavia, Italy.

Matteo Pedrazzoli (M)

Department of Biology and Biotechnologies, University of Pavia, Via Adolfo Ferrata, 9, 27100 Pavia, Italy.

Alessio Murgia (A)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Ivan Ferrari (I)

Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Chiara Cordiglieri (C)

Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Alessandra Fasciani (A)

Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Ernest Arenas (E)

Laboratory for Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Biomedicum, Solnavägen 9, 17177 Stockholm, Sweden.

Dan Felsenfeld (D)

CHDI Management/CHDI Foundation, New York, NY, USA.

Gerardo Biella (G)

Department of Biology and Biotechnologies, University of Pavia, Via Adolfo Ferrata, 9, 27100 Pavia, Italy.

Dario Besusso (D)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Elena Cattaneo (E)

Laboratory of Stem Cell Biology and Pharmacology of Neurodegenerative Diseases, Department of Biosciences, University of Milan, 20122 Milan, Italy.
Istituto Nazionale Genetica Molecolare, Romeo ed Enrica Invernizzi, 20122 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH